Literature DB >> 29203540

Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.

Dominick J Laddy1, Aurelio Bonavia2, Willem A Hanekom3, Deepak Kaushal4, Ann Williams5, Mario Roederer6, Robert A Seder6, Sally Sharpe5, Frank A W Verreck7, Patricia A Darrah8.   

Abstract

Clinical trials of novel tuberculosis (TB) vaccines are expensive, while global resources for TB vaccine development are limited. Therefore, there is a need for robust and predictive preclinical data to support advancement of candidate vaccines into clinical trials. Here, we provide a rationale for using the nonhuman primate as an essential component of these efforts, as well as guidance to the TB community for standardizing experimental design and aligning endpoints to facilitate development of new TB vaccines.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  nonhuman primate; tuberculosis; vaccines

Mesh：

Substances：

Year:  2018        PMID： 29203540      PMCID： PMC5778361          DOI： 10.1128/IAI.00776-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  13 in total

1.  Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails.

Authors:  Frank A W Verreck; Elma Z Tchilian; Richard A W Vervenne; Claudia C Sombroek; Ivanela Kondova; Okke A Eissen; Vinod Sommandas; Nicole M van der Werff; Ernst Verschoor; Gerco Braskamp; Jaco Bakker; Jan A M Langermans; Peter J Heidt; Tom H M Ottenhoff; Klaas W van Kralingen; Alan W Thomas; Peter C L Beverley; Clemens H M Kocken
Journal:  Tuberculosis (Edinb)       Date:  2017-02-20       Impact factor: 3.131

2.  Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison.

Authors:  Philana Ling Lin; Charles A Scanga; JoAnne L Flynn; Pauline Maiello; Robert M DiFazio; Anthony M Cadena; Mark A Rodgers
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 3.  Variation in protection by BCG: implications of and for heterologous immunity.

Authors:  P E Fine
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

4.  Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates.

Authors:  Alexander G White; Pauline Maiello; M Teresa Coleman; Jaime A Tomko; L James Frye; Charles A Scanga; Philana Ling Lin; JoAnne L Flynn
Journal:  J Vis Exp       Date:  2017-09-05       Impact factor: 1.355

5.  Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis.

Authors:  Paul A Luciw; Karen L Oslund; Xiao-Wei Yang; Lourdes Adamson; Resmi Ravindran; Don R Canfield; Ross Tarara; Linda Hirst; Miles Christensen; Nicholas W Lerche; Heather Offenstein; David Lewinsohn; Frank Ventimiglia; Laurie Brignolo; Erik R Wisner; Dallas M Hyde
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

6.  Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model.

Authors:  Philana Ling Lin; Mark Rodgers; Le'kneitah Smith; Matthew Bigbee; Amy Myers; Carolyn Bigbee; Ion Chiosea; Saverio V Capuano; Carl Fuhrman; Edwin Klein; JoAnne L Flynn
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

8.  Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques.

Authors:  K D Kauffman; M A Sallin; S Sakai; O Kamenyeva; J Kabat; D Weiner; M Sutphin; D Schimel; L Via; C E Barry; T Wilder-Kofie; I Moore; R Moore; D L Barber
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

9.  Digitally Barcoding Mycobacterium tuberculosis Reveals In Vivo Infection Dynamics in the Macaque Model of Tuberculosis.

Authors:  Constance J Martin; Anthony M Cadena; Vivian W Leung; Philana Ling Lin; Pauline Maiello; Nathan Hicks; Michael R Chase; JoAnne L Flynn; Sarah M Fortune
Journal:  mBio       Date:  2017-05-09       Impact factor: 7.867

10.  PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis.

Authors:  Philana Ling Lin; Pauline Maiello; Hannah P Gideon; M Teresa Coleman; Anthony M Cadena; Mark A Rodgers; Robert Gregg; Melanie O'Malley; Jaime Tomko; Daniel Fillmore; L James Frye; Tara Rutledge; Robert M DiFazio; Christopher Janssen; Edwin Klein; Peter L Andersen; Sarah M Fortune; JoAnne L Flynn
Journal:  PLoS Pathog       Date:  2016-07-05       Impact factor: 6.823
View more
  11 in total

Review 1.  Research and development of new tuberculosis vaccines: a review.

Authors:  Lewis K Schrager; Rebecca C Harris; Johan Vekemans
Journal:  F1000Res       Date:  2018-11-01

2.  Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates.

Authors:  Ling Shen; James Frencher; Dan Huang; Wandang Wang; Enzhuo Yang; Crystal Y Chen; Zhuoran Zhang; Richard Wang; Arwa Qaqish; Michelle H Larsen; Hongbo Shen; Steven A Porcelli; William R Jacobs; Zheng W Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

Review 3.  Cell Differentiation Degree as a Factor Determining the Role for Different T-Helper Populations in Tuberculosis Protection.

Authors:  Irina Lyadova; Irina Nikitina
Journal:  Front Immunol       Date:  2019-05-08       Impact factor: 7.561

Review 4.  Harnessing donor unrestricted T-cells for new vaccines against tuberculosis.

Authors:  Simone A Joosten; Tom H M Ottenhoff; David M Lewinsohn; Daniel F Hoft; D Branch Moody; Chetan Seshadri
Journal:  Vaccine       Date:  2019-04-27       Impact factor: 3.641

5.  Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques.

Authors:  Andrew D White; Charlotte Sarfas; Laura S Sibley; Jennie Gullick; Simon Clark; Emma Rayner; Fergus Gleeson; Martí Català; Isabel Nogueira; Pere-Joan Cardona; Cristina Vilaplana; Mike J Dennis; Ann Williams; Sally A Sharpe
Journal:  Pharmaceutics       Date:  2020-04-25       Impact factor: 6.321

6.  Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity.

Authors:  Karin Dijkman; Richard A W Vervenne; Claudia C Sombroek; Charelle Boot; Sam O Hofman; Krista E van Meijgaarden; Tom H M Ottenhoff; Clemens H M Kocken; Krista G Haanstra; Michel P M Vierboom; Frank A W Verreck
Journal:  Front Immunol       Date:  2019-11-01       Impact factor: 7.561

7.  The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells.

Authors:  Rachel Tanner; Emily Hoogkamer; Julia Bitencourt; Andrew White; Charelle Boot; Claudia C Sombroek; Stephanie A Harris; Matthew K O'Shea; Daniel Wright; Rachel Wittenberg; Charlotte Sarfas; Iman Satti; Frank A W Verreck; Sally A Sharpe; Helen A Fletcher; Helen McShane
Journal:  F1000Res       Date:  2021-03-30

8.  High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation.

Authors:  Laura Sibley; Andrew D White; Karen E Gooch; Lisa M Stevens; Rachel Tanner; Ashley Jacobs; Owen Daykin-Pont; Fergus Gleeson; Anthony McIntyre; Randall Basaraba; Simon Clark; Graham Hall; Geoff Pearson; Emma Rayner; Helen McShane; Ann Williams; Mike Dennis; Philip D Marsh; Sally Sharpe
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.996

Review 9.  Targeting Unconventional Host Components for Vaccination-Induced Protection Against TB.

Authors:  Elisa Nemes; Shabaana A Khader; Rosemary V Swanson; Willem A Hanekom
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

10.  Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.

Authors:  Julia Bitencourt; Marco Polo Peralta-Álvarez; Morven Wilkie; Ashley Jacobs; Daniel Wright; Salem Salman Almujri; Shuailin Li; Stephanie A Harris; Steven G Smith; Sean C Elias; Andrew D White; Iman Satti; Sally S Sharpe; Matthew K O'Shea; Helen McShane; Rachel Tanner
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.